Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 4.62%11.3B | 4.10%50.28B | 3.54%34.85B | 3.51%23.32B | 6.40%10.8B | 9.51%48.3B | 14.08%33.66B | 19.37%22.53B | 20.01%10.15B | 23.70%44.11B |
| Operating income | 4.62%11.3B | 4.10%50.28B | 3.54%34.85B | 3.51%23.32B | 6.40%10.8B | 9.51%48.3B | 14.08%33.66B | 19.37%22.53B | 20.01%10.15B | 23.70%44.11B |
| Operating expenses | -3.62%-9.22B | -2.34%-28.51B | -4.83%-8.89B | -12.65%-27.86B | -16.36%-8.48B | |||||
| Gross profit | 9.28%2.08B | 9.29%6.34B | 14.42%1.9B | 21.46%5.8B | 42.80%1.66B | |||||
| Selling expenses | -23.23%-691.94K | ---- | 14.40%-2.32M | ---- | 28.21%-561.5K | ---- | 29.97%-2.71M | ---- | 11.36%-782.17K | ---- |
| Administrative expenses | -0.60%-281.72M | ---- | 1.11%-693.21M | ---- | -35.97%-280.04M | ---- | -14.71%-701M | ---- | -1.67%-205.95M | ---- |
| Research and development expenses | 4.88%-251.48M | ---- | -0.10%-914.94M | ---- | 20.93%-264.37M | ---- | -12.97%-913.98M | ---- | -41.72%-334.36M | ---- |
| Profit from asset sales | ---355.98K | ---- | 603.02%177.29K | ---- | --0 | ---- | -94.74%25.22K | ---- | 427.47%1.12M | ---- |
| Employee expense | ---- | -4.22%-8.75B | ---- | -3.22%-4.03B | ---- | -2.32%-8.39B | ---- | -16.53%-3.9B | ---- | -10.63%-8.2B |
| Depreciation and amortization | ---- | -11.51%-7.06B | ---- | -14.69%-3.48B | ---- | -12.90%-6.33B | ---- | -15.58%-3.04B | ---- | -11.04%-5.61B |
| Revaluation surplus | 29.48%15.3M | ---- | -72.25%11.82M | ---- | -63.48%11.82M | ---- | -31.95%42.58M | ---- | -2.62%32.36M | ---- |
| -Changes in the fair value of other assets | 29.48%15.3M | ---- | -72.25%11.82M | ---- | -63.48%11.82M | ---- | -31.95%42.58M | ---- | -2.62%32.36M | ---- |
| Impairment and provision | 1,534.15%7.68M | -3,632.87%-215.15M | -440.78%-65.49M | -1,444.27%-61.25M | 147.34%469.8K | 110.76%6.09M | 185.39%19.22M | 124.41%4.56M | 102.00%189.94K | 28.95%-56.58M |
| -Impairment of property, machinery and equipment | ---- | ---191.1M | ---- | ---82.03M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | 1,534.15%7.68M | -495.01%-24.06M | -440.78%-65.49M | 356.26%20.79M | 147.34%469.8K | 110.76%6.09M | 185.39%19.22M | 124.41%4.56M | 102.00%189.94K | -14.45%-56.58M |
| Special items of operating profit | 8.09%54.02M | 0.64%-28.27B | -30.96%227.08M | 0.43%-12.82B | -34.38%49.98M | -12.37%-28.45B | 8.17%328.93M | -18.25%-12.87B | -34.90%76.17M | -24.47%-25.32B |
| Operating profit | 12.80%1.59B | 17.24%5.92B | 7.49%4.87B | 8.04%2.91B | 15.49%1.41B | 3.96%5.05B | 23.52%4.53B | 36.56%2.69B | 42.14%1.22B | 78.28%4.86B |
| Financing income | -1.80%18.9M | -19.94%94.81M | -19.54%73.47M | -23.05%45.82M | -44.50%19.25M | -34.63%118.42M | -28.25%91.31M | -22.27%59.55M | -22.60%34.69M | 46.75%181.13M |
| Financing cost | 15.43%-136.71M | 16.00%-659.54M | 22.09%-497.38M | 20.90%-355.87M | 28.72%-161.67M | 21.23%-785.14M | 10.16%-638.37M | 7.60%-449.92M | -2.66%-226.82M | -28.27%-996.8M |
| Share of profits of associates | ---- | -2.61%212.98M | ---- | -28.82%68.19M | ---- | 22.64%218.69M | ---- | 29.56%95.8M | ---- | -37.99%178.31M |
| Special items of earning before tax | 89.67%-11.57M | -767.26%-452.14M | 73.02%-31.08M | -916.05%-94.61M | -83.44%-112M | 171.20%67.76M | -288.88%-115.2M | -94.90%11.59M | -162.61%-61.06M | -96.00%24.99M |
| Earning before tax | 2.36%1.16B | 9.56%5.11B | 14.31%4.17B | 6.77%2.57B | 20.12%1.13B | 10.00%4.67B | 15.81%3.65B | 29.34%2.41B | 47.78%940.09M | 42.31%4.24B |
| Tax | ---- | 16.90%-1.05B | ---- | 29.18%-495.32M | ---- | -32.07%-1.27B | ---- | -72.09%-699.4M | ---- | -99.11%-960.24M |
| After-tax profit from continuing operations | -2.69%911.48M | 19.44%4.06B | 28.60%3.39B | 21.47%2.08B | 35.63%936.71M | 3.55%3.4B | 7.19%2.64B | 17.41%1.71B | 51.33%690.64M | 31.35%3.28B |
| After-tax profit from non-continuing business | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- |
| Earning after tax | -2.69%911.48M | 19.44%4.06B | 28.60%3.39B | 21.47%2.08B | 35.63%936.71M | 3.55%3.4B | 7.19%2.64B | 17.41%1.71B | 51.33%690.64M | 31.35%3.28B |
| Minority profit | 12.67%55.79M | -16.79%218.11M | -5.53%181.18M | -3.69%112.93M | -10.17%49.52M | -2.70%262.11M | 2.98%191.78M | 0.20%117.26M | 5.44%55.13M | 91.72%269.37M |
| Profit attributable to shareholders | -3.55%855.69M | 22.47%3.84B | 31.28%3.21B | 23.33%1.96B | 39.60%887.19M | 4.11%3.14B | 7.54%2.44B | 18.92%1.59B | 57.27%635.51M | 27.75%3.01B |
| Basic earnings per share | -3.55%0.1793 | 22.47%0.8051 | 31.37%0.67 | 23.34%0.4116 | 39.56%0.1859 | 4.10%0.6574 | 6.25%0.51 | 18.92%0.3337 | 57.26%0.1332 | 27.76%0.6315 |
| Diluted earnings per share | -5.26%0.18 | 22.47%0.8051 | 23.34%0.4116 | 0.19 | 4.10%0.6574 | 0.3337 | 27.76%0.6315 | |||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.